Here’s whether Precigen, Inc. Common Stock (PGEN) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+2.34% over 10 days); RSI 54 — healthy momentum range; strong 1-year return of +192.8%; 3-month momentum positive (+26.8%); rising volume confirms the move (1.28x 30d avg). Currently 18.6% off its 52-week high. Score: +8/7.
PGEN is in a confirmed uptrend, trading above both its 50-day ($4.12) and 200-day ($4.02) moving averages. An RSI of 54.5 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +192.8% compares to +22.9% for SPY (beat the market by 169.9%).
$10,000 invested 1 year ago→ $29,276 today
vs. S&P 500 (SPY) — same period beat market by 169.9%